Philips stock slips 1.09% to EUR 25.47 premarket
Published on 11/04/2026 at 08:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat investors should watch
- Philips reported 8 percent comparable order intake growth in the third quarter, led by Diagnosis & Treatment.
- Management retained its 2026 targets for 3 percent to 4.5 percent comparable sales growth and a 13.5 percent to 14.0 percent adjusted EBITA margin.
- A 288 million euro Respironics provision reduced reported profit, while Philips reached an agreement in principle with the US Department of Justice.
Philips stock traded at EUR 25.47 on Lang & Schwarz at 08:46 CET on Wednesday, November 4, 2026, 1.09 percent below the Xetra close of Tuesday, November 3, at EUR 25.75. Investors can follow the real-time quote of Philips stock.
Orders improve as legal costs weigh
Philips reported 8 percent comparable order intake growth for the third quarter, driven by its Diagnosis & Treatment business. Group sales increased 3 percent on a comparable basis to EUR 4.4 billion, while the adjusted EBITA margin expanded by 70 basis points to 13.0 percent.
The company retained its full-year 2026 outlook for comparable sales growth of 3 percent to 4.5 percent and an adjusted EBITA margin of 13.5 percent to 14.0 percent. The guidance includes an expected benefit from a US tariff refund, which limits the extent to which the quarter's margin improvement can be read as a purely operational trend.
Reported earnings remained under pressure from the Respironics recall. Philips set aside EUR 288 million in the third quarter after reaching an agreement in principle with the US Department of Justice over previously disclosed criminal and civil investigations. The agreement still requires final documentation, and payment is expected in the first quarter of 2027.
Operating cash flow reached EUR 544 million and free cash flow EUR 384 million in the quarter, according to the Philips third-quarter results release. Investors will weigh stronger orders and margins against legal charges and the company's ability to convert order momentum into sales.
The broader market backdrop is available in the AEX market reports.
